HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)
CUSIP: 40637H109
Q2 2013 13F Holders as of 30 Jun 2013
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,650,000
- Total 13F shares
- 622,083
- Share change
- -47,364
- Total reported value
- $4,941,000
- Price per share
- $7.95
- Number of holders
- 4
- Value change
- -$359,528
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 40637H109:
Top shareholders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NORGES BANK |
13F
|
Company |
0.5%
|
619,773
|
$3,576,000 | — | 31 Mar 2013 | |
| Zurcher Kantonalbank (Zurich Cantonalbank) |
13F
|
Company |
0.07%
|
90,000
|
$519,000 | — | 31 Mar 2013 | |
| Dynamic Technology Lab Private Ltd |
13F
|
Company |
0.05%
|
56,650
|
$327,000 | — | 31 Mar 2013 | |
| MUFG Americas Holdings Corp |
13F
|
Company |
0.01%
|
15,000
|
$101,000 | — | 31 Mar 2013 |
Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q2 2013
As of 30 Jun 2013,
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
622,083 shares.
The largest 4 holders included
CITADEL ADVISORS LLC, Zurcher Kantonalbank (Zurich Cantonalbank), WELLS FARGO & COMPANY/MN, and Dynamic Technology Lab Pte Ltd.
This page lists
4
institutional shareholders reporting positions in this security
for the Q2 2013 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2013 vs Q1 2013 Across Filers
Q1 2013 holders
4
Q2 2013 holders
4
Holder diff
0
| Investor | Q1 2013 Shares | Q2 2013 Shares | Share Diff | Share Chg % | Q1 2013 Value $ | Q2 2013 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.